logo

For the Inventor, By the Inventor

Marburg, Germany

Behringwerke Aktiengesellschaft


USPTO Granted Patents = 340

% Expired Patents = 0.29


Trademarks = 2

Forward Citations = 4,765

Loading Chart...
Loading Chart...

355 inventors (with patents filed for the assignee):

goldMedal Norbert Heimburger (30 out of 38 patents)

silverMedal Edwin F Ullman (27 out of 199 patents)

bronzeMedal Hans Bohn (24 out of 25 patents)

4.  Werner Stuber (20 out of 24 patents)

5.  Klaus Bosslet (17 out of 37 patents)

6.  Cenek Kolar (15 out of 23 patents)

7.  Hans P Kraemer (11 out of 16 patents)

8.  Peter Hermentin (10 out of 17 patents)

9.  Gerhard Dickneite (9 out of 29 patents)

10.  Dieter Hoffmann (9 out of 14 patents)

11.  Gerhardt Kumpe (9 out of 14 patents)

12.  Horst Schwinn (9 out of 16 patents)

13.  Klaus Habenstein (9 out of 16 patents)

14.  Hermann Erich Karges (9 out of 10 patents)

15.  Gerhard Seemann (8 out of 19 patents)


Core Competencies:
Immunoassays
Nucleic Acid Amplification
Tumor-Selective Therapy
Monoclonal Antibodies
Glycoproteins
Peptides
Biosensors
Prodrugs
Genetic Selection
Cell Cultures
Fluorogenic Compounds
Antibodies

340 patents:

1. 8552159 - Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy (2013-10-08),
2. 7273727 - Fusion proteins for prodrug activation (2007-09-25),
3. 6294323 - Self initiating single primer amplification of nucleic acids (2001-09-25),
4. 6162631 - Retrovirus from the HIV group and its use (MVP-2901/94) (2000-12-19),
5. 6124090 - Nucleic acid amplification using single primer (2000-09-26),
6. 6090567 - Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases (2000-07-18),
7. 6020461 - Hexapeptides of Neisseria gonorrhoeae (2000-02-01),
8. 5985550 - Double receptor polynucleotide assay method (1999-11-16),
9. 5981697 - Synthetic peptides, antibodies against them and their use (1999-11-09),
10. 5981227 - Process for the production of proteins (1999-11-09),
11. 5955100 - Prodrugs their preparation and use as pharmaceuticals (1999-09-21),
12. 5939389 - Use of C1-inactivation for therapy of certain diseases (1999-08-17),
13. 5902740 - Process for the decontamination of cell cultures containing mycoplasmas (1999-05-11),
14. 5892144 - Biosensor (1999-04-06),
15. 5883256 - Process for removing aromatic heterocyclic compounds product-containing (1999-03-16),
Behringwerke Aktiengesellschaft is a German pharmaceutical company specializing in the production of biopharmaceuticals. With a history dating back several decades, the company is renowned for its expertise in the field of healthcare. Behringwerke focuses on the development and manufacturing of innovative therapies that target various diseases, including immune disorders and cancer. The company is committed to providing high-quality and safe medications to improve patients' lives and make a positive impact on global health. For more information, please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

340 Patents

#1 in Marburg

#172 in Germany

#2,662 in the World

Marburg, DE
Marburg, Germany

Behringwerke Aktiengesellschaft

Forward Citations = 4,765

355 inventors:

goldMedal Norbert Heimburger (30 out of 38 patents)

silverMedal Edwin F Ullman (27 out of 199 patents)

bronzeMedal Hans Bohn (24 out of 25 patents)

4.  Werner Stuber (20 out of 24 patents)

5.  Klaus Bosslet (17 out of 37 patents)

Please report any incorrect information to [email protected]
Loading…